Multidrug efflux pumps of Pseudomonas aeruginosa show selectivity for their natural substrates
Frontiers in Microbiology · 09.01.2025 · 15
DOI: 10.3389/fmicb.2024.1512472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.01.2025. Verfasst von Léna Mazza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antibiotic-resistant Gram-negative bacteria are an increasing threat to human health. Strategies to restore antibiotic efficacy include targeting multidrug efflux pumps by competitive efflux pump inhibitors. These could be derived from natural substrates of these efflux systems. In this work, we aimed to elucidate the natural substrates of the clinically relevant Mex efflux pumps of Pseudomonas aeruginosa by an untargeted metabolomic approach. We constructed a PA14 mutant, genetically deleted in the major multidrug efflux pumps MexAB-OprM, MexCD-OprJ, MexXY-OprM, and MexEF-OprN and expressed in this mutant each efflux pump individually from an inducible promoter. Comparative analysis of the exo-metabolomes identified 210 features that were more abundant in the supernatant of efflux pump overexpressors compared to the pump-deficient mutant. Most of the identified features were efflux pump specific, while only a few were shared among several Mex pumps. We identified by-products of secondary metabolites as well as signaling molecules. Supernatants of the pump-deficient mutant also showed decreased accumulation of fatty acids, including long chain homoserine lactone quorum sensing molecules. Our data suggests that Mex efflux pumps of P. aeruginosa appear to have dedicated roles in extruding signaling molecules, metabolic by-products, as well as oxidized fatty acids. These findings represent an interesting starting point for the development of competitive efflux pump inhibitors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
- Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.
- School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Zitieren
APA
Mazza, L., Bory, A., Luscher, A., Kloehn, J., Wolfender, J. L., van Delden, C., & Köhler, T. (2025). Multidrug efflux pumps of Pseudomonas aeruginosa show selectivity for their natural substrates. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1512472
Vancouver
Mazza L, Bory A, Luscher A, Kloehn J, Wolfender JL, van Delden C, et al. Multidrug efflux pumps of Pseudomonas aeruginosa show selectivity for their natural substrates. Frontiers in Microbiology. 2025;15. doi:10.3389/fmicb.2024.1512472
BibTeX
@article{Mazza2025,
author = {Mazza, Léna and Bory, Alexandre and Luscher, Alexandre and Kloehn, Joachim and Wolfender, Jean-Luc and van Delden, Christian and Köhler, Thilo},
title = {Multidrug efflux pumps of Pseudomonas aeruginosa show selectivity for their natural substrates},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fmicb.2024.1512472}
}
EUVIMED